Abstract
Thromboembolic disease causes significant morbidity and mortality. This article evaluates those patients at risk and the thromboprophylactic strategies that may be employed.
MeSH terms
-
Anticoagulants / pharmacology
-
Anticoagulants / therapeutic use
-
Bandages
-
Decision Trees
-
Fibrinolytic Agents / pharmacology
-
Fibrinolytic Agents / therapeutic use
-
Hospital Mortality
-
Humans
-
Incidence
-
Risk Factors
-
Thromboembolism / drug therapy
-
Thromboembolism / epidemiology
-
Thromboembolism / prevention & control*
-
Thrombolytic Therapy / methods*
Substances
-
Anticoagulants
-
Fibrinolytic Agents